Earl K. Miller is Picower Professor of Neuroscience at the Massachusetts Institute of Technology, with faculty roles in the Picower Institute for Learning and Memory and the Department of Brain and Cognitive Sciences. His lab focuses on neural mechanisms of cognition, especially working memory, attention and executive control, using both experimental and computational methods. He holds a B.A. from Kent State University and an M.A. and Ph.D. from Princeton University. In 2020, he received an honorary Doctor of Science degree from Kent State University.
Earl K. Miller
Professor of neuroscience
Massachusetts Institute of Technology
Selected articles
- “An integrative theory of prefrontal cortex function” | Annual Review of Neuroscience
- “Top-down versus bottom-up control of attention in the prefrontal and posterior parietal cortices” | Science
- “The importance of mixed selectivity in complex cognitive tasks” | Nature
- “Gamma and beta bursts during working memory readout suggest roles in its volitional control” | Nature Communications
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read